HOOKIPA Pharma Inc.
Biotechnology · Healthcare
CFO
3 appearances
Latest appearance 2023-03-15
Reinhard Kandera
CFO
HOOKIPA Pharma Inc.
Equibles does not estimate personal net worth.
About Reinhard Kandera
Reinhard Kandera is recorded as CFO at HOOKIPA Pharma Inc.. The newest filing on record that lists Reinhard Kandera as CFO at HOOKIPA Pharma Inc. is dated April 26, 2024. HOOKIPA Pharma Inc. reported in an 8-K filed July 26, 2024 that Reinhard Kandera resigned as director, effective July 23, 2024. The proxy statement of HOOKIPA Pharma Inc. reports total compensation of $725,475 for Reinhard Kandera in fiscal 2023, including a base salary of $436,001. Disclosed compensation is on record for 5 fiscal years. Reinhard Kandera has spoken on 3 earnings calls across 1 company, most recently for HOOKIPA Pharma Inc. on March 15, 2023. HOOKIPA Pharma Inc. is classified in the Biotechnology industry within the Healthcare sector.
“Mr. Kandera also resigned from his position as a director of the Company on July 23, 2024 following his separation as Chief Financial Officer as stipulated by his employment agreement with Hookipa Biotech, pursuant to which Mr. Kandera provided services to the Company.”
Reinhard Kandera on recent calls
“So, I want to give you a few highlights of our financial results for the fourth quarter and the full year 2022.”
“I want to give you a few highlights of our financial results for the year 2021, which actually reflects the clinical progress that we have made in the past year.”
“On the financial side of the business, we are looking back to a very successful year in 2020. Despite the progress that we made in our clinical studies, our loss increased only marginally, and our operating cash flow even slightly decreased compared to 2019.”
Affiliation history
-
HOOKIPA Pharma Inc.
CFO
Proxy statement
CurrentStart not stated–present
Last confirmed April 26, 2024
-
HOOKIPA Pharma Inc.
Board Member
Proxy statement
Start not stated–2024-07-23
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | HOOKIPA Pharma Inc. | Chief Financial Officer | $436,001 | $725,475 |
| 2022 | HOOKIPA Pharma Inc. | Chief Financial Officer | $343,531 | $715,161 |
| 2021 | HOOKIPA Pharma Inc. | Chief Financial Officer | $420,541 | $1,175,312 |
| 2019 | HOOKIPA Pharma Inc. | Chief Financial Officer | $352,248 | $1,348,479 |
| 2018 | HOOKIPA Pharma Inc. | Chief Financial Officer | $295,307 | $456,633 |
Recent activity
-
-
Earnings call
HOOKIPA Pharma Inc. Q4 FY2022 Earnings Call
HOOKIPA Pharma Inc.
-
Earnings call
HOOKIPA Pharma Inc. Q4 FY2021 Earnings Call
HOOKIPA Pharma Inc.
-
Earnings call
HOOKIPA Pharma Inc. Q4 FY2020 Earnings Call
HOOKIPA Pharma Inc.